Selective modulation of thrombin-activatable fibrinolysis inhibitor (TAFI) activation by thrombin or the thrombin-thrombomodulin complex using TAFI-derived peptides (Q40572139)

From Wikidata

Jump to navigation Jump to search

scientific article published on 4 September 2015

Language	Label	Description	Also known as
English	Selective modulation of thrombin-activatable fibrinolysis inhibitor (TAFI) activation by thrombin or the thrombin-thrombomodulin complex using TAFI-derived peptides	scientific article published on 4 September 2015

Statements

scholarly article

1 reference

Europe PubMed Central

21 September 2017

Selective modulation of thrombin-activatable fibrinolysis inhibitor (TAFI) activation by thrombin or the thrombin-thrombomodulin complex using TAFI-derived peptides (English)

1 reference

Europe PubMed Central

21 September 2017

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26341360%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

T Plug

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26341360%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

J A Marquart

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26341360%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

P F Marx

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26341360%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

publication date

4 September 2015

1 reference

Europe PubMed Central

21 September 2017

Journal of Thrombosis and Haemostasis

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26341360%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26341360%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26341360%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

2093-2101

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26341360%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U).

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13133

21 January 2018

Recent developments in thrombin-activatable fibrinolysis inhibitor research

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13133

21 January 2018

Regulation of tissue inflammation by thrombin-activatable carboxypeptidase B (or TAFI).

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13133

21 January 2018

Activation and characterization of procarboxypeptidase B from human plasma

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13133

21 January 2018

Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation, thermal stability, and enzymatic properties

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13133

21 January 2018

Crystal structures of TAFI elucidate the inactivation mechanism of activated TAFI: a novel mechanism for enzyme autoregulation

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13133

21 January 2018

The crystal structure of thrombin-activable fibrinolysis inhibitor (TAFI) provides the structural basis for its intrinsic activity and the short half-life of TAFIa

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13133

21 January 2018

Inactivation of active thrombin-activable fibrinolysis inhibitor takes place by a process that involves conformational instability rather than proteolytic cleavage.

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13133

21 January 2018

Activated human plasma carboxypeptidase B is retained in the blood by binding to alpha2-macroglobulin and pregnancy zone protein

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13133

21 January 2018

Thrombin-activatable fibrinolysis inhibitor binds to Streptococcus pyogenes by interacting with collagen-like proteins A and B.

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13133

21 January 2018

The activation peptide of thrombin-activatable fibrinolysis inhibitor: a role in activity and stability of the enzyme?

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13133

21 January 2018

A role for arginine-12 in thrombin-thrombomodulin-mediated activation of thrombin-activatable fibrinolysis inhibitor.

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13133

21 January 2018

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13133

21 January 2018

Dissociation of thrombin's substrate interactions using site-directed mutagenesis

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13133

21 January 2018

Aromatic-aromatic interaction: a mechanism of protein structure stabilization

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13133

21 January 2018

The roles of selected arginine and lysine residues of TAFI (Pro-CPU) in its activation to TAFIa by the thrombin-thrombomodulin complex

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13133

21 January 2018

Flexible or fixed: a comparative review of linear and cyclic cancer-targeting peptides.

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13133

21 January 2018

TAFIa inhibiting nanobodies as profibrinolytic tools and discovery of a new TAFIa conformation.

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13133

21 January 2018

Stabilization versus inhibition of TAFIa by competitive inhibitors in vitro

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13133

21 January 2018

Binding characteristics of thrombin-activatable fibrinolysis inhibitor to streptococcal surface collagen-like proteins A and B

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13133

21 January 2018

Identifiers

10.1111/JTH.13133

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26341360%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

release_77dspfxe7vaenoepvwl5e256jq

1 reference

https://api.fatcat.wiki/v0/release/77dspfxe7vaenoepvwl5e256jq

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26341360%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40572139&oldid=1900650644"